SI
BIIB icon

Sprott Inc’s Biogen BIIB Stock Holding History

Sprott Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,000
Closed -$7.08M – 142
2021
Q3 		$7.08M Hold
25,000
– – 0.46% 51
2021
Q2 		$8.66M Sell
25,000
-15,000
-38% -$4.54M 0.51% 49
2021
Q1 		$11.2M Hold
40,000
– – 0.67% 39
2020
Q4 		$9.79M Buy
40,000
+8,000
+25% +$2.06M 0.53% 45
2020
Q3 		$9.08M Hold
32,000
– – 0.51% 39
2020
Q2 		$8.56K Buy
32,000
+2,000
+7% +$601K 0.54% 30
2020
Q1 		$9.49K Sell
30,000
-5,000
-14% -$1.52M 0.33% 22
2019
Q4 		$10.4K Hold
35,000
– – 0.17% 16
2019
Q3 		$8.15M Buy
35,000
+15,000
+75% +$3.49M 2.08% 18
2019
Q2 		$4.68M Buy
20,000
+5,000
+33% +$1.15M 1.11% 32
2019
Q1 		$3.54K Buy
+15,000
New +$4.72M 0.77% 35

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sprott Inc's BIIB Position: Q4 2021 in Review

Sprott Inc sold out of Biogen (BIIB) in Q4 2021, closing a stake of 25,000 shares — an estimated $7.08M sold.

Sprott Inc first reported a position in BIIB in Q1 2019 and held it in 11 quarters. The position peaked at $11.2M in Q1 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Sprott Inc reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Sprott Inc sold 25,000 Biogen shares in Q4 2021, an estimated $7.08M.
  • Sprott Inc first reported a position in Biogen in Q1 2019 and held it in 11 quarters.
  • Sprott Inc's Biogen position peaked at $11.2M in Q1 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Sprott Inc's 13F filing for Q4 2021, filed 14 Feb 2022.